Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Montreal Heart Institute
Headquarters: Montreal, QC, Canada
Website: http://www.icm-mhi.org
Year Founded: 1954
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Aug 27, 2021
Distillery Therapeutics
Improving cardiac cell therapy for MI with KCNN4 overexpression
BioCentury | Jan 26, 2021
Product Development
Trials of colchicine for COVID-19: Data Byte
Phase III data from the Montreal Heart Institute suggests colchicine could serve as an oral alternative to IV-infused mAbs for COVID-19 in the outpatient setting, but more data are needed. The
BioCentury | Jan 26, 2021
Regulation
Jan. 25 Quick Takes: Comirnaty approved in Australia, authorized in Hong Kong; plus Albireo, Iterum and AZ
Comirnaty (BNT162b2) from BioNTech SE (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) received provisional approval from the Australian Therapeutic Goods Administration and emergency use authorization
BioCentury | Apr 25, 2016
Company News
AstraZeneca, Human Longevity, Genomics England, Wellcome Trust, University of Helsinki, Montreal Heart Institute deal
BioCentury | Feb 8, 2016
Company News
Vanderbilt University, University of Colorado, Partners HealthCare Systems, Montreal Heart Institute, Illumina deal
BioCentury | Feb 4, 2016
Distillery Therapeutics
Therapeutics: Proprotein convertase subtilisin/kexin type 9 (PCSK9); heat shock 90 kDa protein β 1 (Hsp90B1; GP96; GRP94)
Items per page:
1 - 10 of 22